House Dust Mite Observational Study
NCT01949428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2014-05-15
Summary
A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis
Conditions
- Rhinoconjunctivitis
Sponsors & Collaborators
-
Pharm-Olam International
collaborator INDUSTRY -
Circassia Limited
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
NCT01700192 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents
NCT01919554 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis
NCT01008332 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II HDM-SPIRE Safety and Efficacy Study
NCT02150343 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574704 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
NCT00513487 ·Status: COMPLETED ·Phase: NA
-
Ragweed Observational Study
NCT01398137 ·Status: COMPLETED
-
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid
NCT00540631 ·Status: COMPLETED ·Phase: PHASE3
-
ToleroMune House Dust Mite Follow on Study
NCT01923792 ·Status: COMPLETED
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574223 ·Status: COMPLETED ·Phase: PHASE2
-
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
NCT00982163 ·Status: COMPLETED
-
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
NCT00791973 ·Status: COMPLETED ·Phase: PHASE4
-
ToleroMune House Dust Mites (HDM) Exposure Chamber Study
NCT01447784 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model
NCT01527188 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube
NCT00985075 ·Status: COMPLETED
-
Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers
NCT05122143 ·Status: COMPLETED ·Phase: NA
-
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
NCT00800332 ·Status: COMPLETED ·Phase: PHASE2
-
House Dust Mite Allergy Trial In Children
NCT04145219 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
NCT05525650 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC)
NCT00985296 ·Status: COMPLETED
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis
NCT00940953 ·Status: COMPLETED ·Phase: PHASE2
-
Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites
NCT07096440 ·Status: NOT_YET_RECRUITING